Dr. Chiorazzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Community Drive
Manhasset, NY 11030Phone+1 516-562-1090Fax+1 516-562-1011
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Allergy and Immunology, 1983 - 1986
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1973 - 1974
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1970 - 1973
- Georgetown University School of MedicineClass of 1970
- College of the Holy CrossA.B., 1962 - 1966
Certifications & Licensure
- NY State Medical License 1971 - 2026
- NJ State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Diagnostic Laboratory Immunology
Awards, Honors, & Recognition
- Fellow American College of Physicians, 2005
- Recipient, Binet-Rai Medal for Excellence in Chronic Lymphocytic Leukemia Research International Workshop on Chronic Lymphocytic Leukemia, 2003
- Member American Association of Physicians, 2000
- Join now to see all
Clinical Trials
- Human Blood Cell Disorders Tissue Bank Start of enrollment: 2009 Apr 01
- B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging Start of enrollment: 1998 Jul 01
- B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression Start of enrollment: 1999 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsMutation-specific CAR T cells as precision therapy for IGLV3-21expressing high-risk chronic lymphocytic leukemia.Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko
Nature Communications. 2024-02-02 - Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic Leukemia.Gonzalo Blanco, Edward Morris, Jodie L Morris, Hayley L Letson, Suvarna Susheel
Annals of Case Reports. 2024-01-01 - 2 citationsComplete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.Anita Ng, Francesca Lovat, Andrew J Shih, Yuhong Ma, Yuri Pekarsky
Proceedings of the National Academy of Sciences of the United States of America. 2023-10-24
Journal Articles
- miRNAs Involvement in the Pathogenesis of Richter’s SyndromeNicholas Chiorazzi, Alessandra Ferrajoli, Haematologica
- BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemiaChen S-S, Chang BY, Chang S, Tong T, Ham S, Sherry BA, Burger JA, Rai KR, Leukemia, 1/1/2016
- Recurrent RPS15 mutations in chronic lymphocytic leukemia: a novel biomarker of clinical aggressivenessLjungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, Ntoufa S, Baliakas P, Clifford, Sutton L-A, Blakemore S, Stavroyianni N, Agathangelidis A, Rossi D,..., Blood, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?Nicholas Chiorazzi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic LeukemiaNicholas Chiorazzi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- CLL B Cells Develop Resistance to Ibrutinib By Reinvigorating the IL-4R - IL-4 Axis Blocked By BrutonÍs Tyrosine Kinase Inhibitors Including Acalabrutinib and Zanubrut...Nicholas Chiorazzi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- CLL Intraclonal Fractions Defined By Time Since Cell Birth/Division Promote a Leukemia-Supportive, Immune-Tolerant Microenvironment By Distinct Mechanisms2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Ibrutinib Treatment Reduces Myeloid Derived Suppressor Cell Numbers and Function in Chronic Lymphocytic Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Musashi 2 Is Overexpressed in Poor Outcome CLL Patients and Their Proliferative Fraction and Silencing This Gene Induces Apoptosis and Increases Cell Adhesion and Move...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Association of American Physicians Inducts Two Feinstein Institute ResearchersApril 9th, 2019
- CLL in the Era of Targeted TherapiesDecember 12th, 2017
- The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Announces Call for Abstracts for Upcoming Biennial Meeting, May 12-15, 2017November 22nd, 2016
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: